LABU vs IVV

ALABU

BIVV

Measures won1–5IVV wins · of 6 · 3Y

$10,000 · 3Y$35,218LABU · IVV $17,931

Lowest cost0.03%IVV · $3 on $10k

Most income1.11%IVV · $111 on $10k

Smallest drop−8.9%IVV · worst fall in 1Y

Held in common1.6%LABU and IVV

Direxion Daily S&P Biotech Bull 3X Shares · $540MiShares Core S&P 500 ETF · $875B

+52.1%3 years · per year$35,218 · $17,931+21.5%

−29.3%5 years · per year$1,773 · $17,265+11.5%

0.96%Expense ratio$96 · $3 on $10k · lower wins0.03%

0.42%12-mo yield$42 · $111 on $10k1.11%

End-of-day Nov 13, 2026 · $10,000 3 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

3Y2 funds

#			Trend
1	ALABU	Direxion Daily S&P Biotech Bull 3X SharesRead Desk		0.96%	0.42%	−1.7%	+34.8%	+60.7%	+52.1%	−29.3%	−41.8%	$540M
2	BIVV	iShares Core S&P 500 ETFRead Desk		0.03%	1.11%	−0.4%	+11.5%	+11.6%	+21.5%	+11.5%	−8.9%	$875.2B

End-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

3Y2 funds

#			Trend
1	ALABU	Direxion Daily S&P Biotech Bull 3X SharesRead Desk		0.96%	0.42%	−1.7%	+34.8%	+60.7%	+52.1%	−29.3%	−41.8%	$540M
2	BIVV	iShares Core S&P 500 ETFRead Desk		0.03%	1.11%	−0.4%	+11.5%	+11.6%	+21.5%	+11.5%	−8.9%	$875.2B

End-of-day Nov 13, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

LABU

Direxion Daily S&P Biotech Bull 3X Shares

$35,218

IVV

iShares Core S&P 500

$17,931

Loading…